These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 20691029)
1. Efficacy of doxorubicin-based chemotherapy for non-resectable canine subcutaneous haemangiosarcoma. Wiley JL; Rook KA; Clifford CA; Gregor TP; Sorenmo KU Vet Comp Oncol; 2010 Sep; 8(3):221-33. PubMed ID: 20691029 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006). Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321 [TBL] [Abstract][Full Text] [Related]
3. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004). Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000 [TBL] [Abstract][Full Text] [Related]
4. Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma. Finotello R; Stefanello D; Zini E; Marconato L Vet Comp Oncol; 2017 Mar; 15(1):25-35. PubMed ID: 25623994 [TBL] [Abstract][Full Text] [Related]
5. A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma. Teske E; Rutteman GR; Kirpenstein J; Hirschberger J Vet Comp Oncol; 2011 Dec; 9(4):283-9. PubMed ID: 22077409 [TBL] [Abstract][Full Text] [Related]
6. Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma. Borgatti A; Fieberg A; Winter AL; Stuebner K; Taras E; Todhunter D; Masyr A; Rendhal A; Vallera DA; Koopmeiners JS; Modiano JF Vet Comp Oncol; 2020 Dec; 18(4):664-674. PubMed ID: 32187827 [TBL] [Abstract][Full Text] [Related]
8. Surgery alone versus surgery and doxorubicin for the treatment of feline injection-site sarcomas: a report on 69 cases. Martano M; Morello E; Ughetto M; Iussich S; Petterino C; Cascio P; Buracco P Vet J; 2005 Jul; 170(1):84-90. PubMed ID: 15993791 [TBL] [Abstract][Full Text] [Related]
9. Surgery and doxorubicin in dogs with hemangiosarcoma. Ogilvie GK; Powers BE; Mallinckrodt CH; Withrow SJ J Vet Intern Med; 1996; 10(6):379-84. PubMed ID: 8947871 [TBL] [Abstract][Full Text] [Related]
10. Treatment with DAV for advanced-stage hemangiosarcoma in dogs. Dervisis NG; Dominguez PA; Newman RG; Cadile CD; Kitchell BE J Am Anim Hosp Assoc; 2011; 47(3):170-8. PubMed ID: 21498593 [TBL] [Abstract][Full Text] [Related]
11. Outcome of dogs with high-grade soft tissue sarcomas treated with and without adjuvant doxorubicin chemotherapy: 39 cases (1996-2004). Selting KA; Powers BE; Thompson LJ; Mittleman E; Tyler JW; Lafferty MH; Withrow SJ J Am Vet Med Assoc; 2005 Nov; 227(9):1442-8. PubMed ID: 16279389 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996-2011. Burton JH; Powers BE; Biller BJ Vet Comp Oncol; 2014 Sep; 12(3):198-204. PubMed ID: 22905712 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma. Simon D; Moreno SN; Hirschberger J; Moritz A; Kohn B; Neumann S; Jurina K; Scharvogel S; Schwedes C; Reinacher M; Beyerbach M; Nolte I J Am Vet Med Assoc; 2008 Mar; 232(6):879-85. PubMed ID: 18341445 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of radiotherapy alone or in combination with doxorubicin chemotherapy for the treatment of cats with incompletely excised soft tissue sarcomas: 71 cases (1989-1999). Hahn KA; Endicott MM; King GK; Harris-King FD J Am Vet Med Assoc; 2007 Sep; 231(5):742-5. PubMed ID: 17764436 [TBL] [Abstract][Full Text] [Related]
16. Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: a pilot study. Kahn SA; Mullin CM; de Lorimier LP; Burgess KE; Risbon RE; Fred RM; Drobatz K; Clifford CA Can Vet J; 2013 Mar; 54(3):237-42. PubMed ID: 23997259 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin. Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma. Sorenmo KU; Baez JL; Clifford CA; Mauldin E; Overley B; Skorupski K; Bachman R; Samluk M; Shofer F J Vet Intern Med; 2004; 18(2):209-13. PubMed ID: 15058772 [TBL] [Abstract][Full Text] [Related]
20. Clinical outcome in 94 cases of dermal haemangiosarcoma in dogs treated with surgical excision: 1993-2007*. Szivek A; Burns RE; Gericota B; Affolter VK; Kent MS; Rodriguez CO; Skorupski KA Vet Comp Oncol; 2012 Mar; 10(1):65-73. PubMed ID: 22236371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]